Skip to the page

Data / Form D filings / Cure, Inc.

Cure, Inc.: Form D filings

Cure, Inc., a company in New York, NY, filed 7 Form D notices with the SEC between 2018 and 2024. The latest, on September 25, 2024, reports $1.5 million sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
244 Fifth Ave #1269, New York, NY, 10001
Phone
(000) 000-0000
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1751294

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 25, 2024New notice$3,000,000$1,500,000$1,500,0001Sep 9, 2024sec.gov
Aug 25, 2023New notice$2,000,000$365,000$1,635,0004Aug 11, 2023sec.gov
Aug 30, 2022New notice$4,000,000$3,000,000$1,000,00025Aug 15, 2022sec.gov
Feb 1, 2021New notice$2,000,000$1,005,000$995,0006Jan 15, 2021sec.gov
Aug 18, 2020New notice$2,608,103$2,608,10333Aug 5, 2020sec.gov
Jul 16, 2019New notice$1,000,000$25,000$975,0001Jul 1, 2019sec.gov
Aug 28, 2018New notice$500,000$280,000$220,00012Aug 9, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lauren PicassoExecutive Officer, Director

Other companies in New York that filed recently

Every Form D from the week of Sep 23, 2024 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Cure, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.